Suchergebnisse - "Tabarsi, Payam"

PubPharm (37)

1

Clinical and genomic evaluations of a persistent fatal SARS-CoV-2 infection in a goods syndrome patient : a case report

enthalten in: BMC infectious diseases | 2024

von Tabarsi, P. | Maleki, A. | Abtahian, Z. | +6

2

Comparative immunogenicity and safety of SpikoGen®, a recombinant SARS-CoV-2 spike protein vaccine in children and young adults : An immuno-bridging clinical trial

enthalten in: International immunopharmacology | 2024

von Tabarsi, P. | Mamishi, S. | Anjidani, N. | +11

3

Changes in PD-1- and CTLA-4-bearing blood lymphocytes in ICU COVID-19 patients treated with Favipiravir/Kaletra or Dexamethasone/Remdesivir : a pilot study

enthalten in: Iranian journal of allergy, asthma, and immunology | 2023

von Mortaz, E. | Jamaati, H. | K Dezfuli, N. | +9

4

Diminution of STING Expression in the Blood of Patients with Severe or Critical COVID-19 Pneumonia

enthalten in: International archives of allergy and immunology | 2023

von Rezaei, M. | Marjani, M. | Mirahmadi, A. | +9

5

Antibiotic use during the first 6 months of COVID-19 pandemic in Iran : A large-scale multi-centre study

enthalten in: Journal of clinical pharmacy and therapeutics | 2022

von Salehi, M. | Khalili, H. | Seifi, A. | +25

6

Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS-CoV-2 spike protein vaccine as a homologous and heterologous booster vaccination : A randomized placebo-controlled trial

enthalten in: Immunology | 2022

von Tabarsi, P. | Anjidani, N. | Shahpari, R. | +5

7

Effect of COVID-19 pandemic on incidence of mycobacterial diseases among suspected tuberculosis pulmonary patients in Tehran, Iran

enthalten in: International journal of mycobacteriology | 2022

von Aghajani, J. | Farnia, P. | Farnia, P. | +8

8

Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine : a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Tabarsi, P. | Anjidani, N. | Shahpari, R. | +9

9

Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran : findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults

enthalten in: BMJ open | 2022

von Mohraz, M. | Salehi, M. | Tabarsi, P. | +13

ErratumIn: BMJ Open. 2022 Nov 7;12(11):e056872corr1. - PMID 36344009

10

Evaluation of Lymphocyte Subtypes in COVID-19 Patients

enthalten in: Tanaffos | 2022

von Rezaei, M. | Marjani, M. | Tabarsi, P. | +11